Thomas Grinda

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Thomas Grinda
Apr 8, 2025, 09:45 | Drugs
Sarah Sammons: How does Sacituzumab Govitecan perform in active BC brain metastases?
Sarah Sammons, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X: "How…
Nov 15, 2024, 16:18 | Opinion
Erika Hamilton: Harold Burstein and Thomas Grinda on anthracyline use in early breast cancer
Erika Hamilton, the Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on LinkedIn: "Harold…
Nov 10, 2024, 15:41 | Insight
Yakup Ergün: The era of anthracycline-based chemotherapy in early breast cancer is fading
A recent paper by Thomas Grinda, Clinical Research Fellow at Dana-Farber Cancer Institute, was mentioned…
Nov 10, 2024, 03:29 | Insight
Harold J. Burstein: Anthracyclines in Early Breast Cancer - The Long Goodbye
Harold J. Burstein, Breast Cancer Specialist and Professor at Harvard Medical School, shared a recent…
Jun 27, 2024, 16:06 | Blog
COMPASS trial addresses the unmet need of patients with early-relapsing TNBC
Elie Rassy, Medical Oncologist at Gustave Roussy, shared on X: "Just out... COMPASS trial, an academic…
Jan 31, 2024, 15:56 | Blog
Tatiana Prowell: Leptomeningeal disease is one of the great unmet needs in oncology
Tatiana Prowell shared a post by Nancy Lin, Director of the Metastatic Breast Cancer Program at…
Jan 29, 2024, 13:37 | Blog
Sarah Sammons: Learning about Leptomeningeal Disease in Breast Cancer
Sarah Sammons, Breast Medical Oncologist at Dana-Farber's Breast Oncology Center, shared a post on X/Twitter:…
All: 7 Posts: 1 - 100
Special Coverage